Find Articles



Return to:Arthritis Articles
Or:Recent Arthritis Articles

Lilly and MacroGenics Announce Licensing and Collaboration Agreement


http://news.moneycentral.msn.com/provider/providerarticle...

MSN MoneyCentral - We also look forward to working with Lilly to develop next generation CD3 product candidates to potentially treat a variety of autoimmune diseases, such as psoriasis and rheumatoid arthritis." About Teplizumab Teplizumab, also called MGA031, is ...



Article Finder:

October 18, 2007 04:06:00 AM
Article Directory